Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study

(2011) Lubomir Bodnar et al.   GYNECOLOGIC ONCOLOGY

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

(2011) R. Ramasubbaiah et al.   GYNECOLOGIC ONCOLOGY

Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice

(2011) G. Tanigawa et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling

(2010) Noriomi Matsumura et al.   CANCER SCIENCE

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

(2010) Daniela Matei et al.   JOURNAL OF CLINICAL ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE